Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda ® in Patients With Malignant Neoplasms
Conditions: Skin Melanoma; Squamous Non-small-cell Lung Cancer; Head and Neck Squamous Cell Carcinoma Interventions: Drug: RPH-075; Drug: Keytruda ® Sponsors: R-Pharm; Data Management 365; Exacte Labs LLC; Federal State Budgetary Institution " NMIC of Hematology " of the Ministry of Health of the Russian Federation; Federal State Budgetary Institution of the Central Research Institute of Epidemiology of Rospotrebnadzor Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Epidemiology | Head and Neck Cancer | Hematology | HNSCC | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Research | Russia Health | Skin | Skin Cancer | Squamous Cell Carcinoma | Study